Research & Studies

  • PAC Study
  • SAC Study


    To conceptualize abortion stigma and to determine if a school based intervention within the objective will decrease abortion and contraceptive use stigma.


    • To empirically determine what role abortion and contraceptive use stigma play in the environment of a secondary school.
    • To conceptualize abortion and contraceptive use stigma among students, teachers and providers.
  • Power Study

    "In 2015 the WHO recommended taking daily oral PrEP containing ARV based medication used for treatment of HIV for the prevention of HIV in individuals at considerable HIV risk. Demonstration PrEP studies showed very high use, adherence, and success of PrEP medication taken by couples in HIV serodiscordant relationships; men who have sex with men in the Americas and Europe. Kenya last year launched the national Guidelines on Use of PrEP for preventing HIV infection. PrEP is safe and effective and is registered for use by the Pharmacy and Poisons Board in Kenya. Despite these milestones, PrEP is not widely available to young women in part due to policymaker’s need for delivery strategies that effectively reach those at highest risk of HIV, Therefore, effective delivery models for PrEP are needed to determine PrEP use and adherence in these young women who are at highest risk of HIV infection and are motivated to take PrEP, sustain high adherence so long as they remain at risk.


    This study proposes to carry out an evaluation on PrEP medication use, acceptance and successful delivery to young women ages 16-25. We hope to enroll 1000 sexually active HIV negative women followed for up to 36 months. Uptake of and adherence to PrEP will be assessed as Standard Of Care (SOC) PrEP package in public and private family planning clinics at the Jaramogi Oginga Odinga Teaching and Referral Hospital (JOOTRH) and Kisumu Medical Education Trust (KMET) respectively"


    POWER STUDY is allowing young women between ages 16 and 25 to access PrEP. The purpose of this Study is to learn more about young women’s choices to use or not to use PrEP and to understand how best to make PrEP available for women to take to prevent HIV. Up to 3000 young women will be in this study in Kisumu, Kenya Johannesburg and Cape Town, South Africa. In that case, up to 1000 young women will be in the Study in the two-Family Planning-clinics (JOOTRH/ KMET) in Kisumu. Those enrolled will be in the Study for up to 36 months where they will get an opportunity to access PrEP as well as counseling such as Risk reduction and Contraception. Contraceptives will be provided to those who need to use them. These young women will also get an opportunity to be tested and treated for STIs (mainly Chlamydia and Gonorrhea) at no cost. Participation is voluntary and withdrawal is allowed. The Study Staffs will make every effort to keep personal information confidential."

  • PPH Study

    Study aim:

    • evaluate the quality of maternal health care broadly—and of the quality of management of postpartum hemorrhage (PPH) specifically—in Kenya.
    • Understand the actions providers take to prevent, treat and refer cases of PPH and what barriers they may face in providing high quality care.
    • A particular interest in the use of the uterine balloon tamponade (UBT) to manage PPH